Drug Shortage Report for VYVANSE
Report ID | 54721 |
Drug Identification Number | 02439603 |
Brand name | VYVANSE |
Common or Proper name | Lisdexamfetamine Dimesylate capsules |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | LISDEXAMFETAMINE DIMESYLATE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-07-06 |
Estimated end date | 2018-07-16 |
Actual end date | 2018-07-13 |
Shortage status | Resolved |
Updated date | 2018-07-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-07-14 | English | Compare |
v7 | 2018-07-13 | English | Compare |
v6 | 2018-07-13 | French | Compare |
v5 | 2018-07-13 | English | Compare |
v4 | 2018-07-07 | English | Compare |
v3 | 2018-07-06 | French | Compare |
v2 | 2018-07-06 | English | Compare |
v1 | 2018-07-06 | English | Compare |
Showing 1 to 8 of 8